Journal
CELL
Volume 152, Issue 5, Pages 1173-1183Publisher
CELL PRESS
DOI: 10.1016/j.cell.2013.02.022
Keywords
-
Categories
Funding
- NIH [P50 GM081879]
- Howard Hughes Medical Institute
- NSF SynBERC [EEC-0540879]
- Howard Hughes Collaborative Initiative Award
- Ruth L. Kirschstein National Research Service Award
- UCSF Center for Systems and Synthetic Biology
Ask authors/readers for more resources
Targeted gene regulation on a genome-wide scale is a powerful strategy for interrogating, perturbing, and engineering cellular systems. Here, we develop a method for controlling gene expression based on Cas9, an RNA-guided DNA endonuclease from a type II CRISPR system. We show that a catalytically dead Cas9 lacking endonuclease activity, when coexpressed with a guide RNA, generates a DNA recognition complex that can specifically interfere with transcriptional elongation, RNA polymerase binding, or transcription factor binding. This system, which we call CRISPR interference (CRISPRi), can efficiently repress expression of targeted genes in Escherichia coli, with no detectable off-target effects. CRISPRi can be used to repress multiple target genes simultaneously, and its effects are reversible. We also show evidence that the system can be adapted for gene repression in mammalian cells. This RNA-guided DNA recognition platform provides a simple approach for selectively perturbing gene expression on a genome-wide scale.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available